Funding · Healthcare & Life Sciences

Good Monk to add ₹25 crore in pre-Series A extension

By Startup Enthusiast · 5 February 2026

What they do

Good Monk makes sprinkle-on nutrition powders for daily meals and plans to expand in Tier II and III markets

The company turned contribution margin positive and will use the funds for R&D, new formats, and distribution

Existing investor RPSG Capital Ventures leads the round with ₹15.8 crore, joined by Sharrp Ventures and others

Good Monk raised ₹33 crore ($3.65 million) in a pre-Series A funding round.
The round was led by RPSG Capital Ventures.
Hyperscale Ventures also participated in the initial round.
Founders' families joined the round as well.
The company's valuation in this round is ₹175 crore (around $20 million).
Good Monk previously appeared on Shark Tank Season 4 and secured a deal from Vineeta Singh.
The company plans to use the funds for R&D, new product formats, and distribution expansion in Tier II and Tier III markets.

The preventive nutrition market is growing as consumers seek everyday nutrition formats that fit existing food habits.
Good Monk has shown strong growth over the last 18 months and turned contribution margin positive at CM3 level.
This round follows its earlier total funding of nearly $3 million.

Good Monk is the flagship brand of Superfoods Valley.
It sells sprinkle-on nutrition products that are added to daily food like rice, roti, or curd.
Products are sold through its own website, Amazon, and Flipkart.
The company is based in Bengaluru.
It focuses on preventive nutrition — helping consumers add nutrients to their regular meals.

RPSG Capital Ventures (lead) — Venture capital arm of the RP-Sanjiv Goenka Group.
Sharrp Ventures (participated)
Hyperscale Ventures (participated)

Product: Nutrition mixes, multivitamins, probiotics, fiber supplements, and plant protein products.
Customers: Indian consumers, including children, adults, and seniors.
How it makes money: Sells consumer nutrition products directly under a D2C brand.
What sets it apart: Products are designed to blend into daily meals without altering taste or smell and are positioned as clinically validated.
Operations: Expands distribution into Tier II and Tier III markets while investing in R&D and new product formats.